18FDG PET/CT imaging of the pancreas: Spectrum of diseases

Vien X. Nguyen, Cuong C. Nguyen, Ba D. Nguyen

Research output: Contribution to journalEditorialpeer-review

17 Scopus citations


Since the introduction of integrated positron emission tomography-computed tomography (PET/CT), it has a great impact on the field of oncology. Comparing to other conventional scanners, only PET/CT is capable of providing important information on accurate detecting, staging/restaging, and post-therapeutic monitoring of many cancers. Many studies have demonstrated that PET/CT changes the management in approximately 30% of all cancer patients. Because 2-(18F)-fluoro-2-deoxy-D-glucose (FDG) is a nonspecific tracer, understanding the PET/CT limitations and pitfalls for various pancreatic conditions can lead to more accurate interpretation of PET/CT images, which ultimately would impact patient care. As a result, it is important for radiologists and other clinicians to familiarize themselves with a wide spectrum of pancreatic PET/CT findings simulating cancer from benign entities.

Original languageEnglish (US)
Pages (from-to)557-566
Number of pages10
JournalJournal of the Pancreas
Issue number6
StatePublished - Nov 1 2011


  • Fluorodeoxyglucose F18
  • Neoplasm metastasis
  • Pancreas
  • Pancreatic neoplasms
  • Positron-emission tomography;tomography
  • X-ray computed

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology


Dive into the research topics of '18FDG PET/CT imaging of the pancreas: Spectrum of diseases'. Together they form a unique fingerprint.

Cite this